Michael L. Maitland
Program for Appropriate Technology in Health(US)Virginia Cancer Institute(US)University of Virginia(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Statistical Methods in Clinical Trials, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors(1999)1,656 cited
- → CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis(2021)1,557 cited
- → Inflammation, Growth Factors, and Pulmonary Vascular Remodeling(2009)717 cited
- → Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors(2010)406 cited
- → Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer(2007)357 cited
- → Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer(2009)268 cited